Bibliographic Information

Progress in drug research

edited by Ernest Jucker

Birkhäuser, 1998-

  • v. 50
  • v. 51
  • v. 52
  • v. 53
  • v. 54
  • v. 55
  • v. 56
  • v. 57
  • v. 58
  • v. 59
  • Special topic
  • v. 60
  • v. 61

Available at  / 9 libraries

  • 京都大学 大学院薬学研究科・薬学部 図書室薬図

    v. 503||FOR||5098032962, v. 513||FOR||5199032328, v. 523||FOR||5299062224, v. 533||FOR||5399062228, v. 543||FOR||5400013760, v. 553||FOR||5501006900, v. 563||FOR||5601008179, v. 573||FOR||5701056489

  • Kyoto Pharmaceutical University Library

    v. 50499.08||J.1||50096005F, v. 51499.08||J.1||51098415J, v. 52499.08||J.1||52100087A, v. 53499.08||J.1||53101457J, v. 54499.08||J.1||54078197F, v. 55499.08||J.1||55089745B, v. 56499.08||J.1||56103966B, v. 57499.08||J.1||57105718J, v. 58499.08||J.1||58106888B, v. 59499.08||J.1||59108076I

  • 岐阜薬科大学 附属図書館

    v. 50499.28||P.736||5061515, v. 51499.28||P.736||5161932, v. 52499.28||P.736||5262114, v. 53499.28||P.736||5362899, v. 54499.28||P.736||5463170, v. 55499.28||P.736||5563998, v. 56499.28||P.736||5664238, v. 57499.28||.736||5764984, v. 58499.29||P.736||5865977, v. 59499.29||P.736||5966063, v. 60499.28||P.736||6066549

    OPAC

  • 城西大学 水田記念図書館

    v. 500098038523, v. 510098051279, v. 520099041746, v. 530099057654, v. 545200037945, v. 555200054709, v. 565200139993, v. 575200160241, v. 585200241055, v. 595200253469, v. 605200336344, 520099041746, 530099057654, 545200037945, 555200054709, 565200139993, 575200160241, 585200241055, 595200253469, 605200336344

  • Medical Library, The University of Tokyo図書

    v. 51ZP:AD4310659554, v. 52ZP:AD4310676103, v. 53ZP:AD4310699196, v. 54ZP:AD4310717634, v. 55ZP:AD4310743861, v. 56ZP:AD4310765088, v. 57ZP:AD4310786902, v. 58ZP:AD4310806296, v. 59ZP:AD4310836087, v. 60ZP:AD4310868403

  • The Library, Niigata University of Health and Welfare

    v. 51491.5||PR||51100018514, v. 52491.5||PR||52100058163, v. 53491.5||PR||53100058171

  • 福山大学 附属図書館 分館

    v. 50499.08||J129900351, v. 51499.08||J120000241, v. 52499.08||J120000242, v. 53499.08||J120000249, v. 54499.08||J120000250, v. 55499.08||J120100060, v. 56499.08||J120100061, v. 57499.08||J||57120200411, v. 58499.08||J||58120200412, v. 59499.08||J||59120300323, v. 60499.08||J||60120300290

  • 明治薬科大学 図書館

    v. 50499.07||J87||5011050366, v. 51499.07||J87||5111050744, v. 52499.07||J87||5211051563, v. 53499.07||J87||5311052369, v. 54499.07||J87||5411053089, v. 55499.07||J87||5511053902, v. 56499.07||J87||5611054870, v. 57499.07||J87||5711055576, v. 58499.07||J87||5811056360, v. 59499.07||J87||5911056883, Special topic499.07||J87||S-111057584, v. 60499.07||J87||6011057794

  • No Libraries matched.
  • Remove all filters.

Search this Book/Journal

Note

Vol. 61 -- edited by Laszlo Prokai, Katalin Prokai-Tatrai

Vol. 62-: series editors: Paul L. Herriling, Alex Matter

Vol. 68-: series editor: K. D. Rainsford

Vol. 67-: published by Springer

子書誌あり: Special topic, Vol. 61 --<>

Description and Table of Contents

Volume

v. 50 ISBN 9783764358211

Description

Including details of current advances in drug research, this volume includes contributions by P.N. Kaul, M. Rohmer, T.D. Johnson, and R.W. Rockhold.

Table of Contents

  • Drug discovery - past, present and future, P.N. Kaul
  • isoprenoid biosynthesis via the mevalonate-independent route, a novel target for antibacterial drugs?, M. Rohner
  • endothelium-derived hyperpolarizing factor - a critical appraisal, G. Edwards and A.H. Weston
  • glutamatic involvement in psychomotor stimulant action, R.W. Rockhold
  • the identification and development of antiviral agents for the treatment of chronic hepatitis B virus infection, J.M. Colacino and K.A. Staschke
  • polyamines and cerebal ischemia, T.D. Johnson.
Volume

v. 51 ISBN 9783764358228

Description

This volume is part of a series of texts that contain reviews on a wide spectrum of topical areas in pharmaceutical and pharmacological research.

Table of Contents

  • Development of HIV protease inhibitors - a survey, Shijun Ren and Eric J. Lien
  • insulin resistance, impaired glucose tolerance and non-insulin-dependent diabetes, pathologic mechanisms and treatment - current status and therapeutic possibilities, Nicholas C. Turner and John C. Clapham
  • peptide drug delivery into the central nervous system, Laszlo Prokai
  • abnormalities of protein kinases in neurodegenerative diseases, Ravenska T.E. Wagey and Charles Krieger
  • biomimicry as a basis for drug discovery, Vera M. Kolb
  • serotonin in migraine - theories, animal models and emerging therapies, Kirk W. Johnson et al
  • the application of high-throughput screening to novel lead discovery, Barry A. Kenny et al.
Volume

v. 52 ISBN 9783764359799

Description

Founded in 1959, the series has moved from its initial focus on medicinal chemistry to a much wider scope. This volume encompasses all fields concerned with the development of therapeutic drugs, and the elucidation of their mechanisms of action. When combined with the other volumes, it serves as a time-saving source of information for researchers concerned with drug research, and all those who need to keep abreast of ongoing developments in medicines.
Volume

v. 53 ISBN 9783764360283

Description

This text is part of a series which provides expert written reviews on a spectrum of areas in pharmaceutical and pharmacological research. Each volume contains fully cross-referencing indexes which link the books together, forming an encyclopaedic work.
Volume

v. 54 ISBN 9783764361136

Description

This volume covers a range of topics including caco-2 cell permeability versus human gastrointestinal absorption - QSPR analysis; pharmacology of appetite supression; serotonin, dopamine and norepinephrine transporters in the central nervous system and their inhibitors; neuropeptides in drug research; regulation of NMDA receptors by ethanol; and troglitazone and emerging glitazones - new avenues for potential therapeutic benefits beyond glycemic control and applications of developmental biology to medicine and agriculture.
Volume

v. 55 ISBN 9783764361938

Description

Progress in Drug Research is a prestigious book series which provides extensive expert-written reviews on a wide spectrum of highly topical areas in current pharmaceutical and pharmacological research. Founded in 1959 by its current editor, the series has moved from its initial focus on medicinal chemistry to a much wider scope. Today it encompasses all fields concerned with the development of new therapeutic drugs and the elucidation of their mechanisms of action, reflecting the increasingly complex nature of modern drug research. Invited authors present their biological, chemical, biochemical, physiological, immunological, pharmaceutical, toxicological, pharmacological and clinical expertise in carefully written reviews and provide the newcomer and the specialist alike with an up-to-date comprehensive list of prime references. Each volume of Progress in Drug Research contains fully cross-referencing indices which link the books together, forming a virtually encyclopaedic work. The series thus serves as an important, time-saving source of information for researchers concerned with drug research and all those who need to keep abreast of the many recent developments in the quest for new and better medicines.
Volume

v. 56 ISBN 9783764362652

Description

Founded in 1959 by its current Editor, the series has moved from its initial focus on medicinal chemistry to a much wider scope. Today it encompasses all fields concerned with the development of new therapeutic drugs and the elucidation of their mechanisms of action, reflecting the increasingly complex nature of modern drug research. Invited authors present their biological, chemical, biochemical, physiological, immunological, pharmaceutical, toxicological, pharmacological and clinical expertise in carefully written reviews and provide the newcomer and the specialist alike with an up-to-date comprehensive list of prime references. Each volume of Progress in Drug Research contains fully cross-referencing indices which link the books together, forming a virtually encyclopaedic work. The series thus serves as an important, time-saving source of information for researchers concerned with drug research and all those who need to keep abreast of the many recent developments in the quest for new and better medicines.

Table of Contents

Alternative medicine: Herbal drugs and their critical appraisal - Part I.- Current and potential therapies for the treatment of herpesvirus infections.- Quantitiative structure-activity relationships of antianginal drugs.- Purine analogs as CDK enzyme inhibitory agents: A survey and QSAR analysis.- Anti-influenza drugs and neuraminidase inhibitors.- Index Vol. 56.- Index of titles, Vol. 1-56.- Author and paper index, Vol. 1-56.
Volume

v. 57 ISBN 9783764362669

Description

This text provides extensive expert-written reviews on a wide spectrum of topical areas in pharmaceutical and pharmacological research.

Table of Contents

Pushkar N. Kaul and Balawant S. Joshi Alternative medicine: herbal drugs and their critical appraisal - Part II E. Domingo, A. Mas, E. Yuste, N. Pariente, S. Sierra, M. Gutierrez-Rivas and L. Menendez-Arias Virus population dynamics, fitness variations and the control of viral disease: an update Doreen Ma Applications of yeast in drug discovery C.L. Kaul and P. Ramarao Sympathetic nervous system and experimental diabetes: role of adrenal medullary hormones Jay A. Glasel From outer to inner space: traveling along a scientific career from astrochemistry to drug research
Volume

v. 58 ISBN 9783764366247

Description

Jay A. Glasel: Drugs, the human genome, and individual-based medicine.- Vera M. Kolb: Herbal medicine of Wisconsin Indians.- Paul L. Skatrud: The impact of multiple drug resistance (MDR) proteins on chemotherapy and drug discovery.- John W. Ford, Edward B. Stevens, J. Mark Treherne, Jeremy Packer and Mark Bushfield: Potassium channels: Gene family, therapeutic relevance, high-throughput screening technologies and drug discovery.- David T. Wong and Frank P. Bymaster: Dual serotonin and noradrenaline uptake inhibitor class of antidepressants - Potential for greater efficacy of just hype?.- Satya P. Gupta: Advances in QSAR studies of HIV-1 reverse transcriptase inhibitors

Table of Contents

Drugs, the human genome, and individual-based medicine.- Herbal medicine of Wisconsin Indians.- The impact of multiple drug resistance (MDR) proteins on chemotherapy and drug discovery.- Potassium channels: Gene family, therapeutic relevance, high-throughput screening technologies and drug discovery.- Dual serotonin and noradrenaline uptake inhibitor class of antidepressants - Potential for greater efficacy or just hype?.- Advances in QSAR studies of HIV-1 reverse transcriptase inhibitors.- Index Vol. 58.- Index of titles, Vol. 1-58.- Author and paper index, Vol. 1-58.
Volume

v. 59 ISBN 9783764366254

Description

Nikolaus Seiler, Benoit Duranton and Francis Raul: The polyamine oxidase inactivator MDL 72527.- Zhi Hong and Craig E. Cameron: Pleiotropic mechanisms of ribavirin antiviral activities.- Jie Hong Hu and Charles Krieger: Protein phosphorylation networks in motor neuron death.- James O. Schenk: The functioning neuronal transporter for dopamine: kinetic mechanisms and effects of amphetamines, cocaine and methylphenidate.- Laszlo Prokai: Central nervous system effects of thyrotropin-releasing hormone and ist analogues: opportunities and perspectives for drug discovery and development.- David F. Horrobin: A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E).- Suprabhat Ray, Reema Rastogi and Atul Kumar: Current status of estrogen receptors

Table of Contents

Nikolaus Seiler, Benoit Duranton and Francis Raul: The polyamine oxidase inactivator MDL 72527.- Zhi Hong and Craig E. Cameron: Pleiotropic mechanisms of ribavirin antiviral activities.- Jie Hong Hu and Charles Krieger: Protein phosphorylation networks in motor neuron death.- James O. Schenk: The functioning neuronal transporter for dopamine: kinetic mechanisms and effects of amphetamines, cocaine and methylphenidate.- Laszlo Prokai: Central nervous system effects of thyrotropin-releasing hormone and ist analogues: opportunities and perspectives for drug discovery and development.- David F. Horrobin: A new category of psychotropic drugs: neuroactive lipids as exemplified by ethyl eicosapentaenoate (E-E).- Suprabhat Ray, Reema Rastogi and Atul Kumar: Current status of estrogen receptors.- Index Vol. 59.- Index of titles, Vol. 1-59.- Author and paper index, Vol. 1-59
Volume

Special topic ISBN 9783764369262

Description

This second volume of PDR SPECIAL TOPICS contains five review articles, covering nearly the entire field of fungal diseases in humans as well as therapeutic approaches. The main emphasis of the book lies in antifungal therapy: the most relevant information on the present state of the art of antifungal chemotherapy for dermatomycoses, subcutaneous and invasive mycoses is summarized, and open questions and unsolved problems are presented. The book is ideal for both the practitioner as well as advanced student.

Table of Contents

Classification and taxonomy of fungi pathogenic for warm-blooded hosts.- Fungal diseases.- Diagnosis of fungal diseases.- Antifungal therapy - state of the art at the beginning of the 21st century.- Susceptibility testing of fungi - current status and open questions.
Volume

v. 60 ISBN 9783764369873

Description

Progress in Drug Research is a prestigious book series which provides extensive expert-written reviews on a wide spectrum of highly topical areas in current pharmaceutical and pharmacological research. It serves as an important source of information for researchers concerned with drug research and all those who need to keep abreast of the many recent developments in the quest for new and better medicines.

Table of Contents

Chemical and pharmacological investigations of Epimedium species: A survey.- Potential of p38MAP kinase inhibitors in the treatment of cancer.- Therapeutic role of peroxisome proliferator-activated receptors in obesity, diabetes and inflammation.- Quasispecies and the development of new antiviral strategies.- Maximizing the value of genomics in the drug discovery and development process.- Quantitative structure-activity relationships of carbonic anhydrase inhibitors.- Crystallins, genes and cataract.- Current and potential therapies for the treatment of herpesvirus infections.- Index Vol. 60.- Index of titles, Vol. 1-60.- Index and paper index, Vol. 1-60.

by "Nielsen BookData"

Related Books: 1-16 of 16

Details

  • NCID
    BA49098138
  • ISBN
    • 3764358211
    • 376435822X
    • 376435979X
    • 3764360283
    • 3764361131
    • 376436193X
    • 3764362650
    • 3764362669
    • 3764366249
    • 3764366257
    • 3764369264
    • 3764369876
  • Country Code
    sz
  • Title Language Code
    eng
  • Text Language Code
    eng
  • Place of Publication
    Basel
  • Pages/Volumes
    v.
  • Size
    24 cm
Page Top